key: cord-0945060-0t70tkez
authors: Wollina, Uwe; Kanitakis, Jean; Baran, Robert
title: Nails and COVID‐19 – A comprehensive review of clinical findings and treatment
date: 2021-08-22
journal: Dermatol Ther
DOI: 10.1111/dth.15100
sha: 5b7bde74cf9516338fa961a544b841448e5a437f
doc_id: 945060
cord_uid: 0t70tkez

The SARS‐CoV‐2 infection, responsible for COVID‐19, has raised the interest for infection‐associated muco‐cutaneous symptoms. While dermatologic symptoms in general gained an increasing awareness, affection of the nail organ has been mentioned only recently. We provide a narrative review on COVID‐19 manifestation on the nail organ and add symptoms induced by personal protective measures and SARS‐CoV‐2 vaccination. Available treatment options are discussed.

In 2019, a new highly contagious viral disease emerged in China. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified as the responsible pathogen and the disease was termed coronavirus disease-19 . On March 11, 2020 , the WHO declared COVID-19 as a pandemic disease. 1 Cardiovascular and pulmonary symptoms were major clinical symptoms, but soon it was observed that the systemic nature of this infection could affect all organs and tissues of the human body. Although cutaneous manifestations have only rarely been mentioned in the early reports from Wuhan, China, they gained increasing attention later when the pandemic affected Europe and America. 2 The dermatological signs of this systemic infection have been now categorized and have obtained a much better awareness. [3] [4] [5] [6] In contrast to this, nail changes have only recently been identified as possible consequences of SARS-CoV-2-infection. 7 We here review the current knowledge on this topic compared with that of 2020 and added treatment options for the various nail pathologies. and sludge flow (53.7%) was reported. In addition, meandering capillaries and reduced capillary density has been observed in every second patient. Acute COVID-19 infection was associated with a higher prevalence of hemosiderin deposits resulting from micro-hemorrhages and micro-thrombosis. Patients who recovered from COVID-19 had a higher prevalence of capillary pathologies such as enlarged capillaries, meandering capillaries, loss of capillaries, and empty dermal papillae. 8 

One of the most frequently observed cutaneous sign is the COVIDtoe or -finger, a pernio-like periungual erythematous edema ( Figure 1 ). Pernio-like lesions on the fingers or toes typically occur as part of a resolution phase, milder or asymptomatic course of COVID-19, whereas livedoid lesions and retiform purpura are associated with coagulopathy and more severe disease. [3] [4] [5] [6] In one study on 54 patients cryofibrinogenemia was detected in 66.7%. 9 Kanitakis et al. About 50% of patients with COVID-toes or -fingers were positive for SARS-CoV-2. Most patients were young. 13, 14 The serologic negativity in patients with COVID-toes or -fingers might be due to a later seroconversion in milder cases, limited antibody production, or induction of an early robust innate immune response to SARS-CoV-2. 15 The presence of microthrombi in COVIDtoes and -fingers suggests an association with the observed coagulopathy in COVID-19. 10, 16 The most important differential diagnoses include frostbites (perniones) and chilblain lupus erythematosus. In familial chilblain lupus, loss-of-function mutations in the nucleases TREX1 or SAMHD1 have been identified characteristic of a type I interferonopathy. 17 

A rare but severe symptom is acral gangrene ( Figure 5 ). It is a red flag sign of acute severe infection with multisystemic inflammation and cardiovascular malfunction. 

Periungual desquamation has been reported in children with severe Kawasaki-like multisystemic inflammatory syndrome (MIS-C) and adults recovering from severe COVID-19. 21, 22 Since coronary artery lesions have been observed in MIS-C, it has been recommended to assess patients with severe COVID-19 for such vascular symptoms. 23 

Moisturizers can be used to limit the symptoms.

Beau's lines are transverse grooves of the nails resulting from suppressed growth of the nail matrix by drugs or systemic infectious diseases. Beau's lines have been observed among children and adults with COVID-19. [24] [25] [26] Single or multiple nails may be affected-mostly fingernails. Beau's lines can be accompanied by leukonychia. 24 Beau's lines may precede onychomadesis, characterized by separation of the nail plate from the nail matrix, with persistent attachment to the nail bed. Onychomadesis is a possible consequence of COVID-19. 27, 28 Another late manifestation of COVID-19 disease is a heterogeneous red-white discoloration of the nail bed with distal onycholysis. 29 

Onychomadesis and Beau's lines are usually mild and self-limited. In chemotherapy-induced onychomadesis, high-energy 633 nm red light (126 J/cm 2 for 20 min every day) has been successful for fingernails but not toenails. 30 

A red-violet band surrounding the distal margin of the nail lunula, is known as red half-moon sign and has been observed in acute SARS-CoV-2 infection in adult patients. 31, 32 Distal orange discolorations of the nail plates have been reported as a delayed response several weeks after COVID-19 disease in elderly patients who developed later sarcopenia and anemia. 33 Nonblanchable transverse leukonychia (transverse white lines) was observed in a 47-year-old man with COVID-19. These lines are due to abnormal keratinization of the nail plate. 34 F I G U R E 5 Acral purpuric/necrotic lesion from a patient with severe COVID-19 infection. Thrombotic vasculopathy, dermal hemorrhage, and epidermal ischemic necrosis are seen (hematoxylineosin, original magnification Â250)

There is no specific treatment of nail plate discolorations. It is most important to exclude infections (onychomycosis or bacterial infections). Colored nail lacquers can cover the symptoms. Transverse white lines may be persistent after severe damage of nail matrix. The most important differential diagnosis of drug-induced melanonychia is subungual melanoma, which warrants a nail biopsy. 38 

Drug-induced nail changes will most often spontaneously disappear after withdrawal of the responsible drug. No specific treatment exists.

Recently, some cases of pernio-like lesions were reported that developed on the hands and/ or feet a few days after vaccination against COVID-19 with RNA-based vaccines (BionTec/ Pfizer, Moderna). [39] [40] [41] [42] Histologic examination revealed findings indistinguishable from idiopathic and COVID-19-related perniones. 40, 42 2.8.1 | Treatment Low-dose acetylsalicylic acid with oral corticosteroids can be used in symptomatic and painful lesions. Due to temporary character of the vaccine-induced perniones, often treatment is unnecessary.

The green nail syndrome or Goldman-Fox syndrome is caused by nail infection or colonization with P. aeruginosa. It is known as an occupational disease in health care workers, especially in intensive care units.

Green nail syndrome has recently been reported in health care workers during the COVID-19 pandemic ( Figure 6 ). 43, 44 2.9.1 | Treatment Treatment consists of oral ciprofloxacin. Topical treatment includes removal of the onycholytic part of the nail and brushing of the nail bed with 2% sodium hypochlorite solution twice daily for at least 6 weeks, and topical nadifloxacin, tobramycin, or gentamycin. 43, 45 Irritant hand dermatitis has been observed more frequently during the COVID-19 pandemic especially on health care workers on COVID-19 departments. One study reported adverse cutaneous reactions to frequent hand washing and frequent use of disinfectants in up to 80.2%. 46 Nails can be affected due to wet work leading to brittle nails. Loss of cuticle is often seen together with a chronic irritant proximal nail fold dermatitis ( Figure 5 ). 47 Recommendations of skin care have been developed by various medical bodies including the European academy of dermatology and venereology task force on contact dermatitis to avoid adverse effects of sanitary procedures on hands and nails. 46 Limitation of wet work, use of protective gloves, and regular use of moisturizers during the day and emollients overnight are helpful. 

The data that support the findings of this study are openly available in

[PUBMED] at [https://pubmed.ncbi.nlm.nih.gov/].

https://orcid.org/0000-0001-5933-2913

Coronavirus disease (COVID-19) pandemic: an overview of systematic reviews

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases

Cutaneous manifestations related to COVID-19 immune dysregulation in the pediatric age group

Cutaneous signs in COVID-19 patients: a review

The dermatological spectrum of COVID-19 disease: cutaneous signs for diagnostics and prognosis and an expanded classification. Open Access Maced

Nail changes as manifestation of systemic disease in COVID-19 infection

Nailfold capillaroscopy findings in patients with coronavirus disease 2019: broadening the spectrum of COVID-19 microvascular involvement

High prevalence of cryofibrinogenemia in patients with chilblains during the COVID-19 outbreak

COVID toes"): histologic, immunofluorescence, and immunohistochemical study of 17 cases

Bilateral chilblain-like lesions of the toes characterized by microvascular remodeling in adolescents during the COVID-19 pandemic

Lack of association between chilblains outbreak and severe acute respiratory syndrome coronavirus 2: histologic and serologic findings from a new immunoassay

Pediatric COVID toes and fingers

Chilblain-like lesions (cll) associated with COVID-19

Pernio-like eruption associated with COVID-19 in skin of color

Chilblains is a common cutaneous finding during the COVID-19 pandemic: a retrospective nationwide study from France

Familial chilblain lupus due to a gainof-function mutation in STING

Acral gangrene: ugly cousin of "COVID toes" in multisystem inflammatory syndrome in children associated with SARS-COV-2?

COVID-19-associated coagulopathy and disseminated intravascular coagulation

Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19

Periungual desquamation in a Japanese adult recovering from severe COVID-19

Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study

Beau-lines of the fingernails in association with pediatric SARS-CoV-2 infections

Beau's lines and leukonychia in a COVID-19 patient

Beau lines associated with COVID-19

Onychomadesis following COVID-19 infection: is there a relationship?

A review of nail findings associated with COVID-19 infection

Heterogeneous red-white discoloration of the nail bed and distal onycholysis in a patient with COVID-19

Onychomadesis associated with chemotherapy: case report and mini literature review

COVID-19 and nail manifestation: be on the lookout for the red half-moon nail sign

The red half-moon nail sign: a novel manifestation of coronavirus infection

Transverse orange nail lesions following SARS-CoV-2 infection

Transverse leukonychia (Mees' lines) nail alterations in a COVID-19 patient

Yellow-white fluorescence on the nails: a novel finding of Favipiravir used for the treatment of COVID-19

Fluorescence of nails and hair on Wood's lamp examination in Covid pandemic; undefined effect of Favipiravir in humans

Longitudinal melanonychia and skin hyperpigmentation associated with hydroxychloroquine therapy

Clinical and dermoscopic clues to differentiate pigmented nail bands: an international Dermoscopy society study

Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registrybased study of 414 cases

Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that 'COVID toes' are due to the immune reaction to SARS-CoV-2

Blue toes' following vaccination with the BNT162b2 mRNA COVID-19 vaccine

A case of chilblains-like lesions post SARS-CoV-2 vaccine?

The Goldman-fox syndrome: treating and preventing green pseudomonas nails in the era of COVID-19

Chloronychia in healthcare workers in COVID-19 times

Retrospective case series on risk factors, diagnosis and treatment of Pseudomonas aeruginosa nail infections

Prospective study on hand dermatitis in nurses and doctors during COVID-19 pandemic and its improvement by use of adopted recommendations of the European academy of dermatology and venereology task force on contact dermatitis

Hand dermatitis and nail disorders of the workplace

Nails and COVID-19 -A comprehensive review of clinical findings and treatment